GlassScriptPhysician profile
Jeffrey J Mutchler
NPI 1205946449
$13,289.57
in general payments reported to CMS, 2019-2025
11 companies · $1,798 in 2025
The $1,798 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,457 · 2020: $2,631 · 2021: $788 · 2022: $2,117 · 2023: $874 · 2024: $2,625 · 2025: $1,798.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,185 · Food and Beverage: $1,112.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,185.36 |
| Food and Beverage | $1,111.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Titan Surgical Group, LLC | $5,004.26 | 2020-2025 | |
| Elite Orthopedics, LLC | $4,232.95 | 2022-2025 | |
| Arthrex, INC. | $3,697.78 | 2019-2025 | |
| Depuy Synthes Sales INC. | $132.88 | 2020-2023 | Velys |
| Smith+Nephew, INC. | $71.79 | 2022 | |
| Baudax Bio INC. | $38.00 | 2020-2021 | |
| Wright Medical Technology, INC. | $36.97 | 2019 | |
| Pacira Therapeutics, INC. | $27.12 | 2019-2020 | |
| Conmed Corporation | $16.37 | 2025 | Visiclear |
| Kowa Pharmaceuticals America, INC. | $16.26 | 2023 | Seglentis |
| Ferring Pharmaceuticals INC. | $15.19 | 2024 | Euflexxa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Mutchler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.